Cargando…
The gut-lung axis in the CFTR modulator era
The advent of CFTR modulators represents a turning point in the history of cystic fibrosis (CF) management, changing profoundly the disease’s clinical course by improving mucosal hydration. Assessing changes in airway and digestive tract microbiomes is of great interest to better understand the mech...
Autores principales: | Lussac-Sorton, Florian, Charpentier, Éléna, Imbert, Sébastien, Lefranc, Maxime, Bui, Stéphanie, Fayon, Michael, Berger, Patrick, Enaud, Raphaël, Delhaes, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540301/ https://www.ncbi.nlm.nih.gov/pubmed/37780857 http://dx.doi.org/10.3389/fcimb.2023.1271117 |
Ejemplares similares
-
Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023) -
New Insights in Microbial Species Predicting Lung Function Decline in CF: Lessons from the MucoFong Project
por: Francis, Florence, et al.
Publicado: (2021) -
The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks
por: Enaud, Raphaël, et al.
Publicado: (2020) -
Effects of Lumacaftor-Ivacaftor on Airway Microbiota-Mycobiota and Inflammation in Patients with Cystic Fibrosis Appear To Be Linked to Pseudomonas aeruginosa Chronic Colonization
por: Enaud, Raphael, et al.
Publicado: (2023) -
The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis
por: Enaud, Raphaël, et al.
Publicado: (2018)